Rare lephants
Screener

Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jun 28, 2023 FORM 8-K
8-K Jun 23, 2023 FORM 8-K
4 Jun 20, 2023 FORM 4
4 Jun 5, 2023 FORM 4
8-K Jun 1, 2023 FORM 8-K
8-K May 22, 2023 FORM 8-K
10-Q May 15, 2023 FORM 10-Q
8-K May 15, 2023 FORM 8-K
4 May 5, 2023 FORM 4
4 May 5, 2023 FORM 4
4 May 5, 2023 FORM 4
4 May 5, 2023 FORM 4
4 May 5, 2023 FORM 4
8-K May 4, 2023 FORM 8-K
DEFA14A Apr 26, 2023 FORM DEFA14A
8-K Apr 26, 2023 FORM 8-K
8-K Apr 4, 2023 FORM 8-K
ARS Mar 30, 2023
DEF 14A Mar 30, 2023 FORM DEF 14A
10-K Mar 22, 2023 FORM 10-K
8-K Mar 22, 2023 FORM 8-K
8-K Mar 13, 2023 FORM 8-K
4 Mar 6, 2023 FORM 4
4 Mar 6, 2023 FORM 4
SC 13G/A Feb 9, 2023 SCHEDULE 13G/A
← Newer Page 6 of 26 · 641 filings Older →